10,406 followers
Researchers from @NUFeinbergMed report IGF-1 & IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in potential future #Parkinsons clinical trials, "without posing significant logistical or regulatory challenges" https://t.co/p2F